SCHEMBL23947795

SCHEMBL23947795

c1ccc(-c2nc(-c3ccc4c(c3)oc3cc(-c5ccc6c7ccccc7n(-c7ccccc7)c6c5)ccc34)nc(-c3ccc4oc5ccccc5c4c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CHEK2 O96017 1/20 0.37
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
HCRTR1 O43613 1/20 0.35
PLA2G10 O15496 1/20 0.34
MMP12 P39900 2/20 0.34
MMP13 P45452 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
AHR P35869 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23947525 1.00 KDM4E (0.41) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL24264029 1.00 KDM4E (0.41) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL21192242 1.00 KDM4E (0.41) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL21192244 1.00 KDM4E (0.41) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL23947527 1.00 KDM4E (0.41) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL23947797 1.00 KDM4E (0.41) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL24264430 1.00 KDM4E (0.41) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL21192068 0.99 KDM4E (0.40) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL22240756 0.99 KDM4E (0.42) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL22257891 0.99 KDM4E (0.42) KDM4EATML3MBTL1CHEK2PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 KDM4E 3842/4885ATM 2218/4885L3MBTL1 94/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 KDM4E 3695/4885ATM 2154/4885L3MBTL1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.